Key points from article :
Every 1-2 seconds, a diabetic gets a foot ulcer.
South Korea-based medical startup, ROKIT Healthcare, has come up with a radical regenerative solution.
Treatment is “autologous” – implanted tissue is sourced from patients’ own cells.
Now being applied to knee cartilage regeneration and is in the experimental stage of regenerating donated kidneys.
Pioneering with Diabetic foot ulcers potentially extends to multiple skin or tissue conditions.
Extending its concept beyond tissue to deal with bone and organ conditions.
Registered “Dr Invivio” bioprinter with the US Food and Drug Administration as a medical device.
Generates revenue by selling the patient kits for each treatment.
Micro-scanning technology embedded in printers create a 4D laser cutter, potentially, replace human surgeons.
De-cell, re-cell machine for washing and replacing organs with patients’ DNA should be ready for operational use in April.
“People are living longer and this will reduce medical expenses.” - You Seok-hwan, CEO of ROKIT.
